Life sciences company Neogen (NASDAQ:NEOG) reported Q4 CY2025 results , but sales fell by 2.8% year on year to $224.7 million. The company’s full-year revenue guidance of $850 million at the midpoint ...

Life sciences company Neogen (NASDAQ:NEOG) will be reporting results this Thursday before the bell. Here’s what to expect. Neogen beat analysts’ revenue expectations by 2.6% last quarter, reporting ...

Shares of life sciences company Neogen (NASDAQ:NEOG) fell 24% in the afternoon session after the company provided updated Q4 fiscal 2025 outlook that pointed to temporary headwinds impacting gross ...

Neogen Corporation supports global food and animal safety as nasdaq 100 etf discussions include life sciences companies.

Neogen Corporation reported its fiscal Q3 2025 earnings, revealing an unexpected rise in earnings per share (EPS) but a miss on revenue forecasts. The company posted an EPS of $0.10, surpassing the ...

Shares of life sciences company Neogen (NASDAQ:NEOG) jumped 27.6% in the morning session after the company reported fourth-quarter results that far surpassed Wall Street's expectations and raised its ...

Neogen Corporation supports global food and animal safety while appearing in broader market discussions involving the nasdaq index fund.